259 related articles for article (PubMed ID: 9387029)
1. Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.
Rosenberg L
Int J Pancreatol; 1997 Oct; 22(2):81-93. PubMed ID: 9387029
[TBL] [Abstract][Full Text] [Related]
2. Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.
Boeck S; Heinemann V
J Clin Oncol; 2008 Mar; 26(7):1178-9; author reply 1179. PubMed ID: 18309957
[No Abstract] [Full Text] [Related]
3. [Results of gemcitabine hydrochloride in the treatment for pancreatic cancer].
Tsukagoshi S
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1461-7. PubMed ID: 11681259
[TBL] [Abstract][Full Text] [Related]
4. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
5. New developments in chemotherapy for patients with advanced pancreatic cancer.
Rothenberg ML
Oncology (Williston Park); 1996 Sep; 10(9 Suppl):18-22. PubMed ID: 8884803
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer.
Tomao S; Romiti A; Massidda B; Ionta MT; Farris A; Zullo A; Brescia A; Santuari L; Frati L
Anticancer Res; 2002; 22(4):2361-4. PubMed ID: 12174927
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
8. Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions.
Xiong HQ; Carr K; Abbruzzese JL
Drugs; 2006; 66(8):1059-72. PubMed ID: 16789792
[TBL] [Abstract][Full Text] [Related]
9. [Gemcitabine treatment of pancreatic cancer peritonitis].
Horiki N; Maruyama M; Fujita Y; Suzuki Y; Tanaka T; Shimomura M; Tanigawa K; Sasaki H; Fujiwara M; Suzuki K; Imoto I; Adachi Y
Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):73-8. PubMed ID: 12601933
[No Abstract] [Full Text] [Related]
10. [Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer].
Yokoyama A
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1294-300. PubMed ID: 10945029
[TBL] [Abstract][Full Text] [Related]
11. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
12. Gemcitabine: a ray of hope for pancreatic cancer?
Gupta P
Natl Med J India; 1997; 10(2):72-3. PubMed ID: 9153984
[No Abstract] [Full Text] [Related]
13. Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.
Saif MW
JOP; 2006 Jul; 7(4):337-48. PubMed ID: 16832131
[TBL] [Abstract][Full Text] [Related]
14. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook.
Eriksson B; Oberg K
Ann Oncol; 1999; 10 Suppl 2():S31-8. PubMed ID: 10399030
[TBL] [Abstract][Full Text] [Related]
15. Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
Saif MW
JOP; 2008 Mar; 9(2):91-8. PubMed ID: 18326919
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine resistance in pancreatic cancer: picking the key players.
Kim MP; Gallick GE
Clin Cancer Res; 2008 Mar; 14(5):1284-5. PubMed ID: 18316544
[No Abstract] [Full Text] [Related]
17. Current and future strategies for treating metastatic pancreatic cancer.
Berlin JD
Clin Adv Hematol Oncol; 2004 Aug; 2(8):510-2. PubMed ID: 16163230
[No Abstract] [Full Text] [Related]
18. [Contribution of gemcitabine in the treatment of advanced pancreatic cancer].
Brunet R; Fonck M
Rev Med Interne; 1999 Sep; 20(9):816-20. PubMed ID: 10522306
[TBL] [Abstract][Full Text] [Related]
19. [Gemcitabine and pancreatic cancer].
Prost P; Ychou M; Azria D
Bull Cancer; 2002 Aug; 89 Spec No():S91-5. PubMed ID: 12449037
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.
Kozuch P; Petryk M; Evans A; Bruckner HW
Surg Clin North Am; 2001 Jun; 81(3):683-90. PubMed ID: 11459281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
